Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies

Gregory J. Kubicek, Maria Werner-Wasik, Mitchell Machtay, Gayle Mallon, Thomas Myers, Michael Ramirez, David Andrews, Walter J. Curran, Adam P. Dicker

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint Dive into the research topics of 'Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy